News

As per the terms of the collaboration, BAC developed CaptureSelect custom affinity ligands for use in monitoring Genmab UniBody drug candidates in preclinical studies and clinical trials, and

APS001 is a new anticancer agent currently under development at Anaeropharma Science that utilises characteristic features of Bifidobacterium longum. Eisai’s both contracts cover the development of drugs that

Most recently, Forster was the CEO of Solace Pharmaceuticals. Before joining Solace Pharma, Forster was the head of EU Development and of Development Operations in the EU &

Cevec Pharma also added that the virus titers are as good as or even higher than with MDCK and Vero cells, host cells currently used for influenza vaccine

MedQuist’s transcription solutions feed clinical documents directly into CodeRunner CAC, which helps in speeding the coding process to obtain reimbursement faster and lower a facility’s DNFBs (Discharged Not

Onko-Sure is a simple, non-invasive, patent-pending and regulatory-approved in-vitro diagnostic test for the monitoring of colorectal cancer and for lung cancer detection and treatment monitoring by measuring the

HBI-8000 has now entered into a Phase I clinical trial in the US under an IND application with the FDA. HBI-8000 trial is designed to assess safety, tolerability

Xerclear, a patented combination of 5% acyclovir and 1% hydrocortisone in Medivir’s proprietary cream formulation, is a topical product for the treatment of recurrent herpes labialis. As per

The facility is housed with three Clinical Pharmacology Units with an 80 bed facility to cater to both early and late phase development as well as life cycle